Given that CAC is a specific subtype of CRC in humans, despite their distinct etiology, clinical features, and molecular characteristics, the scarcity of clinical specimens for CAC drives our primary focus towards exploring the potential common role of SIX4 in CRC specimens. This evidence concerns the gene SIX4 and colorectal carcinoma.